Literature DB >> 2236362

Psychiatric consequences of temporal lobectomy for intractable seizures: a 20-30-year follow-up of 14 cases.

J R Stevens1.   

Abstract

Between 1958 and 1968, 14 patients from the epilepsy clinic at the University of Oregon Hospitals and Clinics with a diagnosis of temporal lobe epilepsy (TLE) had a temporal lobectomy for medically intractable seizures. Nine of the 14 patients operated on remained seizure-free over the 20-30-year period of follow-up. Between 6 months and one year following temporal lobectomy, two women, previously healthy from a psychiatric standpoint, developed psychoses, and the previous psychiatric problems of four other patients worsened. Two patients, one with incapacitating paranoid personality disorder and the other with explosive rage attacks preoperatively, had marked improvement in their psychiatric status following temporal lobectomy. The remaining six patients, all psychiatrically healthy prior to surgery, have had no change in psychiatric status following surgery. Development of psychosis or deterioration in psychiatric status after surgery was more common in patients with later age of onset, unreality or déjà vu rather than epigastric aura, pre-operative evidence of bilateral brain damage, and persistence of EEG or clinical seizure activity. Development of a chronic psychosis in psychiatrically healthy individuals many months after temporal lobectomy, even when seizures are arrested or ameliorated, suggests that anomalous synaptic regeneration may follow the surgery in these cases. Careful analysis of histories and outcomes may contribute to better understanding of the pathophysiology and anatomical substrates of psychoses.

Entities:  

Mesh:

Year:  1990        PMID: 2236362     DOI: 10.1017/s0033291700017049

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  9 in total

Review 1.  Behaviour changes following temporal lobectomy, with special reference to psychosis.

Authors:  M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

Review 2.  Neuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiology.

Authors:  Tracy Butler; Daniel Weisholtz; Nancy Isenberg; Elizabeth Harding; Jane Epstein; Emily Stern; David Silbersweig
Journal:  Epilepsy Behav       Date:  2011-12-29       Impact factor: 2.937

3.  Psychiatric morbidity after surgery for epilepsy: short-term follow up of patients undergoing amygdalohippocampectomy.

Authors:  A S Naylor; L Kessing; C Kruse-Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

4.  Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors.

Authors:  P Shaw; J Mellers; M Henderson; C Polkey; A S David; B K Toone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 5.  Brain modules of hallucination: an analysis of multiple patients with brain lesions.

Authors:  Claude M J Braun; Mathieu Dumont; Julie Duval; Isabelle Hamel-Hébert; Lucie Godbout
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

6.  Psychosis following temporal lobe surgery: a report of six cases.

Authors:  C J Mace; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

7.  The pathophysiology of body dysmorphic disorder.

Authors:  Jamie D Feusner; Jose Yaryura-Tobias; Sanjaya Saxena
Journal:  Body Image       Date:  2008-03-07

Review 8.  Epilepsy and obsessive-compulsive disorder.

Authors:  Peter W Kaplan
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

9.  Does antiepileptic drug withdrawal predispose patients undergoing temporal lobe epilepsy surgery to late onset of psychiatric morbidity? A report of three cases.

Authors:  Garima Shukla; Priya Agarwal; Rajesh Sagar; Mamta Sood; Aditya Gupta; Ashish Suri; Ajay Garg
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.